Biosimilars
An Introduction to Biosimilars
Biologics have become an important component of the therapeutic landscape, but agents are associated with high costs. Biosimilars are more affordable and therefore enable more patient access to these treatment options. Education around the use of biosimilars and the challenges of their use in the real-world setting are important to ensure successful incorporation into the treatment pathway.
Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.